 ?您的位置：對照品 > 對照品 > 國家對照品 > |
|
|
|
| 產品基本信息 |
|
| 產品編號：H325800 |
| 產品名稱：Higenamine Hydrobromide Salt |
| 產品CAS：63604-85-3 |
| 規格含量：250mg |
| 產品價格：面議 |
| 聯系我們: |
 |
|
 |
|
|
| 產品詳細介紹 |
| 標準品編號: |
H325800 |
| 名稱: |
Higenamine Hydrobromide Salt |
| 別名: |
1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol Hydrobromide; (+/-)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6,7-isoquinolinediol Hydrobromide; (+/-)-O-demethyl-Coclaurine Hydrobromide; (RS)-Norcoclaurine Hydrobromide; (+/-)-Demethylcoclaurine Hydrobromide; (+/-)-Norcoclaurine Hydrobromide; (+/-)-O-Demethylcoclaurine Hydrobromide; dl-Demethylcoclaurine Hydrobromide |
| CAS號: |
63604-85-3 |
| 參考CAS號: |
Free Base: 5843-65-2 / HCl: 11041-94-4 |
| 分子式: |
C??H??BrNO? |
| 外觀: |
白色至白色固體 |
| 熔點: |
>245°C (dec.) |
| 分子量: |
352.22 |
| 儲存: |
冰箱 |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
Higenamine acts through inhibition of middle cerebral artery occlusion (MCAO)-mediated HMGB1 release in vivo. Useful towards ischemic injuries. |
| 參考文獻 |
|
|
|
|
|
|
|
|
